| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.AMJCARD.2004.08.013 |
| P698 | PubMed publication ID | 15566910 |
| P2093 | author name string | Emile R Mohler | |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aorta | Q101004 |
| P304 | page(s) | 1396-402, A6 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Mechanisms of aortic valve calcification | |
| P478 | volume | 94 |
| Q53119954 | A novel marker of inflammation in patients with slow coronary flow: lymphocyte-to-monocyte ratio. |
| Q63707053 | Activation of the calcium-sensing receptor in human valvular interstitial cells promotes calcification |
| Q42657732 | Age-related changes in aortic valve hemostatic protein regulation |
| Q35985691 | All-cause mortality in hemodialysis patients with heart valve calcification |
| Q41166213 | Altered MicroRNA Expression Is Responsible for the Pro-Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves |
| Q50749422 | An epigenetic regulatory loop controls pro-osteogenic activation by TGF-β1 or bone morphogenetic protein 2 in human aortic valve interstitial cells. |
| Q35147157 | Animal models of calcific aortic valve disease |
| Q36288730 | Aortic stenosis: medical and surgical management |
| Q87621757 | Aortic valve calcification and increased stiffness of the proximal thoracic ascending aorta: association with left ventricular diastolic dysfunction and early chronic kidney disease |
| Q36220601 | Aortic valve calcification in 499 consecutive patients referred for computed tomography |
| Q33767188 | Aortic valve: mechanical environment and mechanobiology |
| Q33583872 | Augmented osteogenic responses in human aortic valve cells exposed to oxLDL and TLR4 agonist: a mechanistic role of Notch1 and NF-κB interaction |
| Q80377156 | Bone formation in cardiac valves: a histopathological study of 128 cases |
| Q36487128 | Calcific aortic valve damage as a risk factor for cardiovascular events |
| Q41486764 | Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. |
| Q34920768 | Characterization of cell subpopulations expressing progenitor cell markers in porcine cardiac valves. |
| Q37871512 | Circulating osteogenic cells: implications for injury, repair, and regeneration |
| Q41894232 | Crystalline ultrastructures, inflammatory elements, and neoangiogenesis are present in inconspicuous aortic valve tissue |
| Q52673823 | Crystallinity of hydroxyapatite drives myofibroblastic activation and calcification in aortic valves. |
| Q36117837 | Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments |
| Q92343929 | Development of calcific aortic valve disease: Do we know enough for new clinical trials? |
| Q43105408 | Differences in associated factors between aortic and mitral valve calcification in hemodialysis. |
| Q34590497 | Differences in valvular and vascular cell responses to strain in osteogenic media |
| Q44171958 | Direction and magnitude of blood flow shear stresses on the leaflets of aortic valves: is there a link with valve calcification? |
| Q35315207 | Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells |
| Q37362752 | Does lowering cholesterol have an impact on the progression of aortic stenosis? |
| Q48831205 | Dynamic deformation characteristics of porcine aortic valve leaflet under normal and hypertensive conditions |
| Q47733081 | Effect of pioglitazone on inflammation and calcification in atherosclerotic rabbits : An (18)F-FDG-PET/CT in vivo imaging study |
| Q30654838 | Effects of shear stress pattern and magnitude on mesenchymal transformation and invasion of aortic valve endothelial cells |
| Q37239791 | Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment |
| Q33947156 | Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner |
| Q33781161 | Ethnic differences in aortic valve thickness and related clinical factors |
| Q34534867 | Gentamicin Reduces Calcific Nodule Formation by Aortic Valve Interstitial Cells In Vitro |
| Q41608987 | HIF-1α and VEGF: Immunohistochemical Profile and Possible Function in Human Aortic Valve Stenosis |
| Q90267043 | Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease |
| Q42138851 | Hypercholesterolemia induces side-specific phenotypic changes and peroxisome proliferator-activated receptor-gamma pathway activation in swine aortic valve endothelium |
| Q37150843 | Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential |
| Q80255835 | Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve |
| Q37468098 | In situ elasticity modulation with dynamic substrates to direct cell phenotype |
| Q36367630 | In-vitro analysis of early calcification in aortic valvular interstitial cells using Laser-Induced Breakdown Spectroscopy (LIBS). |
| Q46247463 | Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis |
| Q36959236 | Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells |
| Q35116249 | Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly |
| Q35022323 | Insight into pathologic abnormalities in congenital semilunar valve disease based on advances in understanding normal valve microstructure and extracellular matrix |
| Q35070613 | Insights into aortic sclerosis and its relationship with coronary artery disease |
| Q36546306 | Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology. |
| Q35668536 | Laminin Peptide-Immobilized Hydrogels Modulate Valve Endothelial Cell Hemostatic Regulation. |
| Q50205280 | Lysophosphatidylcholine activates the Akt pathway to upregulate extracellular matrix protein production in human aortic valve cells |
| Q37623938 | Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification |
| Q85098581 | Medical treatments in aortic stenosis: Role of statins and angiotensin-converting enzyme inhibitors |
| Q92157061 | MicroRNA-204 Deficiency in Human Aortic Valves Elevates Valvular Osteogenic Activity |
| Q92368937 | MicroRNA-638 inhibits human aortic valve interstitial cell calcification by targeting Sp7 |
| Q91670867 | MicroRNAs fingerprint of bicuspid aortic valve |
| Q34181316 | Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries |
| Q38978261 | Mitral valve endothelial cells with osteogenic differentiation potential. |
| Q30474772 | Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification |
| Q34349804 | Noticeable decreased expression of tenascin-X in calcific aortic valves |
| Q67406317 | Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation. |
| Q99408896 | Oscillatory fluid-induced mechanobiology in heart valves with parallels to the vasculature |
| Q35660101 | Pathogenesis of aortic stenosis: not just a matter of wear and tear |
| Q37987807 | Pathophysiologic mechanisms of calcific aortic stenosis |
| Q33941107 | Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves--association with low BMP antagonists and SMAD6 |
| Q88634184 | Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases |
| Q28506607 | Reduced sox9 function promotes heart valve calcification phenotypes in vivo |
| Q39573172 | Regression of aortic valve stenosis by ApoA-I mimetic peptide infusions in rabbits. |
| Q40230321 | Regulation of valvular interstitial cell calcification by adhesive peptide sequences |
| Q43003872 | Regulation of valvular interstitial cell calcification by components of the extracellular matrix |
| Q62046431 | Regulatory mechanisms in vascular calcification |
| Q35563353 | Role for circulating osteogenic precursor cells in aortic valvular disease |
| Q54224456 | Role of Wnt/β-catenin signaling pathway in the mechanism of calcification of aortic valve. |
| Q37592503 | Role of the MAPK/ERK pathway in valvular interstitial cell calcification |
| Q34600308 | Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation |
| Q34483004 | Sex, Aging, and Preexisting Cerebral Ischemic Disease in Patients With Aortic Stenosis |
| Q27336001 | Sex-related differences in gene expression by porcine aortic valvular interstitial cells |
| Q47975076 | Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells |
| Q36667389 | Statins and progression of calcified aortic stenosis |
| Q36980132 | Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels |
| Q41954773 | Substrate properties influence calcification in valvular interstitial cell culture |
| Q50110073 | The Contribution of Whole Blood Viscosity to the Process of Aortic Valve Sclerosis |
| Q33787707 | The effects of combined cyclic stretch and pressure on the aortic valve interstitial cell phenotype |
| Q42318438 | The role of valve interstitial cells in valve disease |
| Q37579906 | Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases. |
| Q48084858 | Translating calcified aortic valve disease to the bench - Use of 3D matrices in the development of future treatment strategies. |
| Q42373714 | Valve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification. |
| Q33908760 | Valvular aortic stenosis: a proteomic insight |
| Q36765026 | Visualizing novel concepts of cardiovascular calcification |
Search more.